Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML
2024 · Annals of Hematology · 12 citations
https://doi.org/10.1007/s00277-024-05760-6
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
91
Citations
6
h-index
3
i10-index
Quinto Gesiotto is an academic researcher from Thomas Jefferson University Hospital. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Lymphoma Diagnosis and Treatment & Viral-associated cancers and disorders. The author has an h-index of 6, co-authored 17 publications.
ORCID: 0000-0001-9574-0375https://doi.org/10.1007/s00277-024-05760-6
https://doi.org/10.7759/cureus.10960
https://doi.org/10.7759/cureus.15132
https://doi.org/10.7759/cureus.15256
Click to start Chat